Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019732 · ClinicalTrials.gov registry record
Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States
A clinical trial, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- 1
- Enrollment target
NCT02019732 is a clinical trial that has completed, run by GlaxoSmithKline. The registered enrollment target is 1 participants.
The verdict
NCT02019732 has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
This is a database study to quantify the burden of multiple mild outcomes (i.e., those that result in visits to a physician's office) attributable to influenza in the United States, stratified by age group, geographic region and influenza subtype for selected influenza seasons.
Interventions
- OTHER Data collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02019732
The ClinicalTrials.gov registry entry for NCT02019732 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Data collection is the first listed.
NCT02019732 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02019732 about?
NCT02019732 is a clinical study titled "Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States". This is a database study to quantify the burden of multiple mild outcomes (i.e., those that result in visits to a physician's office) attributable to influenza in the United States, stratified by age group, geographic region and influenza subtype for selected influenza seasons.
What is the current status of trial NCT02019732?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2013-01. Estimated completion is 2013-06.
What interventions are being tested in trial NCT02019732?
The interventions under investigation include: Data collection (OTHER).
Who is sponsoring clinical trial NCT02019732?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.